BioSpace News Archive

Interventional Radiology Drainage Procedures Market Size US$ 1.4 Bn by 2030

The global interventional radiology drainage procedures market is expected to reach the value of US$ 1.4 Bn by 2030, at a CAGR of 7% during the forecast period.

July 21, 2022
·
13 min read
Business

NeuroPace to Report Second Quarter 2022 Financial Results on August 11, 2022

NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the second quarter 2022 after market close on Thursday, August 11, 2022.

July 21, 2022
·
1 min read
Interventional Pulmonology Market Size to Surpass US$ 8 Bn by 2030

This explains why the market is estimated to register a striking CAGR of 9% during the forecast period and to reach around US$ 8 Bn by 2030.

July 21, 2022
·
9 min read
Business

Corvus Pharmaceuticals Appoints Dr. James Rosenbaum Senior Vice President of Research

Corvus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced the appointment of James Rosenbaum, M.D. as Senior Vice President of Research, effective immediately.

July 21, 2022
·
7 min read
Business

Cytokinetics to Announce Second Quarter Results on August 4, 2022

Cytokinetics, Incorporated announced that it is scheduled to report second quarter results on August 4, 2022 at 4:00 PM Eastern Time.

July 21, 2022
·
3 min read
Drug Development

DICE Therapeutics Announces Completion of Enrollment in Phase 1 Clinical Trial of Lead Oral IL-17 Antagonist, DC-806, for the Treatment of Psoriasis

DICE Therapeutics, Inc. (Nasdaq: DICE), today announced the completion of enrollment in the Company’s Phase 1 clinical trial of DC-806 in healthy volunteers and psoriasis patients.

July 21, 2022
·
5 min read
Pharm Country

Adaptimmune to Report Q2 2022 Financial Results and Business Updates on Thursday, August 4, 2022

Adaptimmune Therapeutics plc (NASDAQ: ADAP), a leader in cell therapy to treat cancer, will report financial results and provide business updates for the second quarter ended June 30, 2022, before the US markets open on Thursday, August 4, 2022.

July 21, 2022
·
2 min read
Agarose Bead Technologies triples its production capacity with major manufacturing expansion

Agarose Bead Technologies (ABT), a key player in the life science industry, plans a major expansion of its manufacturing capabilities, tripling its production capacity to meet the global demand for agarose resins.

July 21, 2022
·
3 min read
Job Trends

Pfizer announces PREVNAR (pneumococcal 20-valent conjugate vaccine) is now available in Canada for the prevention of pneumonia and invasive pneumococcal disease in adults 18 years of age and older

Pfizer Canada ULC announced today that PREVNAR 20 (Pneumococcal 20-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) is now available in Canada for the prevention of pneumonia and invasive pneumococcal disease (including sepsis, meningitis, bacteremic pneumonia, pleural empyema and bacteremia).

July 21, 2022
·
9 min read
Biotech Bay

Embolx Files 510(k) for New Soldier® High Flow Microcatheter

Embolx, Inc, today announced that the company has filed a 510(k) to the Food and Drug Administration (FDA) for its new product line of high flow microcatheters called “Soldier,” that uses the same Ultra-Thin Wall (UTW) technology initially developed for its flagship product Sniper®.

July 21, 2022
·
1 min read